# Safety and Efficacy of EN3835 in Participants With Frozen Shoulder

> **NCT04496167** · PHASE2 · COMPLETED · sponsor: **Endo Pharmaceuticals** · enrollment: 198 (actual)

## Conditions studied

- Adhesive Capsulitis
- Frozen Shoulder

## Interventions

- **DRUG:** EN3835
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04496167
- **Lead sponsor:** Endo Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-07-29
- **Primary completion:** 2022-04-14
- **Final completion:** 2022-04-14
- **Target enrollment:** 198 (ACTUAL)
- **Last updated:** 2023-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04496167

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04496167, "Safety and Efficacy of EN3835 in Participants With Frozen Shoulder". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04496167. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*